Incidence of Thrombotic Cardiovascular Events in Patients Taking Celecoxib Compared with Those Taking Rofecoxib: Interim Results from the New Zealand Intensive Medicines Monitoring Programme

Author： Harrison-Woolrych Mira  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.5, 2005-01, pp. : 435-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Events in Patients taking Varenicline: A Case Series from Intensive Postmarketing Surveillance in New Zealand

By Harrison-Woolrych Mira  

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 33-43

Adis International

Access to resources Recommend Favorite

Signal Generation in the New Zealand Intensive Medicines Monitoring Programme: A Combined Clinical and Statistical Approach

By Coulter D.M.  

Drug Safety, Vol. 25, Iss. 6, 2002-01 ,pp. : 433-439

Adis International

Access to resources Recommend Favorite

Celecoxib and rofecoxib ADRs compared with meloxicam

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan: An Observational Study

By Huang Weng-Foung  

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 261-272

Adis International

Access to resources Recommend Favorite

Celecoxib associated with similar cardiovascular risk to rofecoxib

By  

Reactions Weekly, Vol. 1, Iss. 1048, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite